BioGend Therapeutics Co., Ltd. (TPEX: 6733)
Taiwan
· Delayed Price · Currency is TWD 37.30
-0.30 (-0.80%)
Oct 11, 2024, 9:39 AM CST
BioGend Therapeutics Revenue
BioGend Therapeutics had revenue of 37.27M TWD in the quarter ending June 30, 2024, a decrease of -3.12%. This brings the company's revenue in the last twelve months to 133.45M, up 91.07% year-over-year. In the year 2023, BioGend Therapeutics had annual revenue of 109.91M with 249.51% growth.
Revenue (ttm)
133.45M
Revenue Growth
+91.07%
P/S Ratio
34.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.63B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition